Press Releases

August 10, 2020

Thermo Fisher Scientific Develops COVID-19 Antibody Assay Targeting Transplant Community

Powerful new solution provides more accurate COVID-19 antibody detection

WEST HILLS, Calif., Aug. 10, 2020 /PRNewswire/ -- Thermo Fisher Scientific continues to expand its response to the COVID-19 pandemic, developing a new serological assay targeted towards transplant candidates and recipients that can detect antibodies directed against COVID-19 (SARS-CoV-2). The assay will be provided under the company's One Lambda brand representing leading in vitro diagnostic products for the transplant community. This novel antibody detection panel is part of Thermo Fisher's continued efforts to support transplant patients during the pandemic.
"A semi-quantitative multiplex assay that can simultaneously detect the response to spike, receptor-binding domain, nucleocapsid and other SARS-CoV-2 proteins will be a huge step forward towards fully characterizing the immune response to COVID-19"
Dr. Robert Bray | co-director of the Emory University Hospital HLA laboratory

 

Read full Press Release

 

Follow us:  
Facebook LinkedIn Twitter